[1]戴政文,钟传棋,杨志新.桂枝芍药知母汤治疗痛风性关节炎急性期疗效及对患者可调节相关因子与嘌呤受体水平变化的影响[J].陕西中医,2024,(1):67-70.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.015]
　DAI Zhengwen,ZHONG Chuanqi,YANG Zhixin.Study on the changes of regulating related factors and purine receptors in the treatment of gouty arthritis by Guizhi Shaoyao Zhimu decoction[J].,2024,(1):67-70.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.015]
点击复制

桂枝芍药知母汤治疗痛风性关节炎急性期疗效及对患者可调节相关因子与嘌呤受体水平变化的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
67-70
栏目:
临床研究
出版日期:
2024-01-05

文章信息/Info

Title:
Study on the changes of regulating related factors and purine receptors in the treatment of gouty arthritis by Guizhi Shaoyao Zhimu decoction
作者:
戴政文1; 2; 3; 钟传棋1; 2; 3; 杨志新1; 2; 3
(1.湖北省中医院,湖北 武汉 430061; 2.湖北中医药大学附属医院, 湖北 武汉 430061; 3.湖北省中医药研究院, 湖北 武汉 430074)
Author(s):
DAI Zhengwen;  ZHONG Chuanqi;  YANG Zhixin
(Hubei Provincial Hospital of Traditional Chinese Medicine,Wuhan 430061,China)
关键词:
痛风性关节炎急性期;  桂枝芍药知母汤;  非布司他;  塞来昔布;  血尿酸;  血沉
Keywords:
Acute states of gouty arthritis;  Guizhi Shaoyao Zhimu decoction;  Colchicine;  Celecoxib;  Blood uric acid;  Sedimentation
分类号:
R 684.3
DOI:
DOI:10.3969/j.issn.1000-7369.2024.01.015
文献标志码:
A
摘要:
目的:观察桂枝芍药知母汤联合非布司他、塞来昔布治疗痛风性关节炎(GA)急性期的效果,为临床治疗提供参考。方法:选取GA患者110例,根据随机原则分为对照组(西药)和观察组(桂枝芍药知母汤+西药),每组55例。记录两组治疗前及治疗3、7 d后血尿酸(UA)、血沉(ESR)、白细胞介素-1β(IL-1β)、Diekkopf-1(DKK-1)、白细胞介素-18(IL-18)、嘌呤能受体(P2X7R)水平及中医证候积分的变化,统计两组疗效和不良反应。结果:治疗7 d后,观察组总有效率为90.91%(50/55),明显高于对照组的76.36%(42/55),差异有统计学意义(P<0.05)。治疗3、7 d后,两组皮色皮温、全身症状及关节相关积分较治疗前下降,观察组低于对照组,且两组治疗7 d后低于治疗3 d后(P<0.05)。治疗3、7 d后,两组UA、IL-1β、DKK-1、IL-18、P2X7R、ESR较治疗前下降,观察组低于对照组,且两组治疗7 d后上述因子低于治疗3 d后(P<0.05)。观察组不良反应发生率为9.09%(胸闷1例、胃肠道症状4例),与对照组的20.00%(胸闷2例、胃肠道症状8例和皮疹1例)比较,差异无统计学意义(P>0.05)。结论:桂枝芍药知母汤联合西药治疗GA急性期可减轻症状,提高疗效,可能与调节相关因子的表达水平有关。
Abstract:
Objective:To observe the effect of Guizhi Shaoyao Zhimu decoction combined with colchicine and celecoxib in treating acute stage of gouty arthritis,and to provide reference for clinical treatment.Methods:110 patients with gout arthritis in the acute stage were randomly divided into a conventional group(treated with western medicine)and a decoction group(treated with western medicine+ Guizhi Shaoyao Zhimu decoction),with 55 patients in each group.Recorded the changes in the levels of blood uric acid(UA),sedimentation(ESR),interleukin-1 β(IL-1 β),interleukin-18(IL-18),Diekkopf-1(DKK-1),purinergic receptor(P2X7R)and TCM syndrome score before and after 3 d and 7 d,efficacy and adverse effects included in group 2 were calculated,and TCM syndrome score were calculated.Results:After 7 days of treatment,the total effective rate of the observation group was 90.91%(50/55),which was significantly higher than that of the control group 76.36%(42/55),with statistical significance(P<0.05).After 3 and 7 days of treatment,skin color skin temperature,systemic symptoms and joint related scores in both groups were lower than before treatment,the observation group was lower than the control group,and the two groups were lower than after 7 days of treatment(P<0.05).After 3 and 7 days of treatment,UA,IL-1β,DKK-1,IL-18,P2X7R and ESR in both groups were lower than before treatment,the observation group was lower than the control group,and the above factors were lower after 7 days of treatment than after 3 days of treatment(P<0.05).The incidence of adverse reactions in the observation group was 9.09%(1 case of chest tightness and 4 cases of gastrointestinal symptoms),compared with 20.00%(2 cases of chest tightness,8 cases of gastrointestinal symptoms and 1 case of rash)in the control group,there was no statistical significance(P>0.05).Conclusion:Guizhi Shaoyao Zhimu decoction combined with western medicine in the treatment of acute gouty arthritis can reduce symptoms and improve the curative effect,which may be related to regulating the expression levels of related factors.

参考文献/References:

[1] 时文睿,渠鸿竹,方向东.痛风的多组学研究进展[J].遗传,2023,45(8):643-657.
[2] 刘元德,李昊.小剂量秋水仙碱联合美洛昔康治疗痛风性关节炎疗效观察[J].海南医学,2018,29(17):2486-2489.
[3] 李越,邹月芬,徐磊,等.痛风性关节炎急性发作期DECT影像特征与临床表现的相关性研究[J].临床放射学杂志,2023,42(4):651-655.
[4] CARREL K L,CHI C M.Clinical usefulness of HLA-B58:Genotyping in gouty arthritis[J].Journal of Clinical Rheumatology and Immunology,2019,19(1):27-33.
[5] 罗明辉,刘金文.基于数据挖掘探讨中医药治疗痛风性关节炎用药规律[J].陕西中医,2020,41(9):1320-1323.
[6] 朱慧敏.桂枝芍药知母汤加味辨治风寒湿痹型急性痛风性关节炎45例[J].河南中医,2019,39(4):508-511.
[7] 中华医学会.临床诊疗指南风湿病分册[M].北京:人民卫生出版社,2005:123.
[8] 沈鹰.风湿病中西医诊疗概要[M].北京:人民军医出版社,2006:225.
[9] 国家食品监督管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:179.
[10] 杨丽华,刘晓丽,蒋雅琼,等.我国痛风的患病率及危险因素[J].医学研究杂志,2019,48(12):4-6,10.
[11] 周莲婷,赵威,蒙向欣.中药痛风方治疗湿热蕴结型急性痛风性关节炎的临床疗效观察[J].广州中医药大学学报,2023,40(6):1394-1398.
[12] NIDHI G,VENUS K,DILEEP K J,et al.Gouty tophi presenting as multinodular lateral inguinal swelling:A case report[J].Diagnostic Cytopathology,2018,46(9):801-803.
[13] 王晓锋,季春香,黄碧霞.彩色多普勒超声血流分级对痛风性关节炎患者的早期临床诊断分析[J].影像研究与医学应用,2022,6(17):77-79.
[14] 王海霞.非布司他联合塞来昔布治疗痛风性关节炎的临床疗效观察[J].中国药物与临床,2019,19(5):759-761.
[15] 张秦,侯堃,邵培培,等.中医多元外治法治疗痛风性关节炎急性期疗效观察[J].北京中医药,2017,36(4):353-355.
[16] 范海霞,刘健,黄传兵,等.黄芩清热除痹胶囊联合西药治疗急性痛风性关节炎的临床效果[J].世界中医药,2021,16(17):2600-2604,2610.
[17] 李莉,潘红梅,裴国超,等.清热除湿方内服和肿痛消外敷治疗湿热蕴结型急性痛风性关节炎60例[J].环球中医药,2020,13(3):428-430.
[18] 牛燕运,郑娜,胡翠平,等.祛湿清热法治疗痛风性关节炎的临床研究[J].中国中医急症,2020,29(1):76-78,94.
[19] 陈胜,魏合伟,郑维蓬.清热凉血方联合凉性经筋通贴膏治疗痛风性关节炎的临床观察[J].中国中医急症,2018,27(5):885-887.
[20] 欧凡,郭健,刘婷.加味桂枝附子汤联合依托考昔治疗寒湿痹阻型急性痛风性关节炎的疗效[J].中国老年学杂志,2020,40(1):122-125.
[21] 石少华,许宗颖,于瀚,等.桂枝芍药知母汤方证解析[J].中医药学报,2019,47(3):27-28.
[22] 李芨慧,李玉宏,葛丽丽.急性痛风性关节炎患者肌骨超声半定量评分与红细胞沉降率、白细胞介素-6水平及疾病活动度相关性分析[J].陕西医学杂志,2022,51(3):318-321.
[23] 张弢,隋淼,于扬,等.痛风患者尿KIM-1、NGAL、IL-18表达及与肾损伤的关系[J].中国中西医结合肾病杂志,2020,21(1):25-28.
[24] 李胜酋,黄培同,林嘉茜,等.活血清热中药联合苯溴马隆治疗高尿酸血症继发痛风性关节炎疗效及对血尿酸、DKK-1、TRAP-5b的影响[J].现代中西医结合杂志,2018,27(10):1123-1126.
[25] 郭玉星,熊辉,周彪,等.Nod样受体家族含pyrin结构域蛋白3和嘌呤能离子通道型受体7在急性痛风性关节炎发病中的作用研究进展[J].中医正骨,2018,30(8):39-41,49.

相似文献/References:

[1]刘志宇,朱 琳.基于血清生化指标及DAS28、HAQ评分变化探究桂枝芍药知母汤联合西药在老年类风湿关节炎急性期治疗中的应用效果[J].陕西中医,2024,(5):638.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.014]
　LIU Zhiyu,ZHU Lin.Application effect of Guizhi Shaoyao Zhimu decoction combined with western medicine on elderly patients with acute stage of rheumatoid arthritis based on changes in serum biochemical indicators,DAS28 score and HAQ score[J].,2024,(1):638.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.014]

备注/Memo

备注/Memo:
基金项目:湖北省中医药中西医结合科研项目[鄂卫生计生通(2017)20 号]
更新日期/Last Update: 2024-01-09